Related Articles
Clusterin: A potential target for improving response to antiestrogens
miR‑342 is associated with estrogen receptor‑α expression and response to tamoxifen in breast cancer
The broad-spectrum metalloproteinase inhibitor BB-94 inhibits growth, HER3 and Erk activation in fulvestrant-resistant breast cancer cell lines
EZH2 inhibition sensitizes tamoxifen‑resistant breast cancer cells through cell cycle regulation
Berberine enhances the anti‑tumor activity of tamoxifen in drug‑sensitive MCF‑7 and drug‑resistant MCF‑7/TAM cells